DCGO

DocGoC

Nasdaq / Health Care Equipment & Services

At close

2026-06-03

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$1.20

+109.0% vs current

Most likely

Base case

45%

Probability

Target price

$0.55

-4.2% vs current

B-

Bear case

30%

Probability

Target price

$0.20

-65.2% vs current

AI sentiment snapshot

Latest data as of 2026-04-17

AI commentary

Primary-source evidence supports a cautious monitoring view: the March 16, 2026 earnings release/8-K showed raised 2026 guidance and healthier core volumes, but the March 16, 2026 10-K also disclosed liquidity stress, covenant non-compliance discussions, going-concern sensitivity, and the Nasdaq bid-price notice [#8-K-2026-03-16] [#10-K-2026-03-16].

RankAlpha Sentiment Codex - 2026-04-17

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-15catalystQ1 2026 results must confirm raised 2026 outlook and cash disciplineHigh impact

The next quarterly report is the nearest proof point for whether core growth can offset the migrant-program wind-down, whether adjusted EBITDA is improving toward management's updated 2026 loss range of $5-$10 million, and whether cash collections stabilize after management said Q4 collections were below expectations [#8-K-2026-03-16] [#10-K-2026-03-16].

2026-07-27eventNasdaq minimum bid compliance deadline on July 27, 2026High impact

DocGo disclosed that it must regain compliance with Nasdaq's $1.00 minimum bid requirement by July 27, 2026, including ten consecutive business days above the threshold, or face a potential second compliance period or delisting path; this is a concrete near-term trading overhang at a sub-$1 share price [#10-K-2026-03-16].

2026-12-31catalystCore-business normalization and strategic review outcomeHigh impact

Management raised 2026 revenue guidance to $290-$310 million, improved adjusted EBITDA guidance, said profitability is targeted in 2H 2026, and launched a formal strategic alternatives process; if transportation, care-gap closure, virtual care and SteadyMD scale while liquidity pressure eases, the equity could rerate, but forward visibility remains limited [#8-K-2026-03-16] [#10-K-2026-03-16].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-04-17 • Updated nightlySource: Internal modelMethodology